The differentiation of pancreatic ductal adenocarcinoma (PDAC) could be associated with prognosis and may influence the choices of clinical management. No applicable methods could reliably predict the tumor differentiation preoperatively. | Non-invasively predicting differentiation of pancreatic cancer through comparative serum metabonomic profiling